Recent studies have found that depleted levels of ApoA1 might may a role in the pathophysiology of various neurodegenerative disorders, such as Alzheimer’s disease (Lin et al., 2015) and depression (Morris et al., 2021). This evidence concerns the gene APOA1 and major depressive disorder.